---
figid: PMC7382785__nihms-1608678-f0005
figlink: pmc/articles/PMC7382785/figure/F4/
number: F4
caption: Illustration of aptamer involvement in cancer immunotherapy. (A) Two most
  crucial (most known) immune checkpoints. (B) Antagonistic aptamers, selected against
  either receptor or ligand, inhibit their interaction. Therefore, the downstream
  pathway is not triggered. Agonistic aptamers dimerize receptor dimers that result
  in switching on respective signaling. (C) Selected immune system receptors that
  have already been targeted by aptamers. (D) Whereas standard approaches use aptamers
  as targeting agents to deliver therapeutic cargo to cells, aptamer-engineered NK
  cells are directed by cell-membrane-embedded aptamers to lymphoma cells.
pmcid: PMC7382785
papertitle: Aptamers as Modular Components of Therapeutic Nucleic Acid Nanotechnology.
reftext: Martin Panigaj, et al. ACS Nano. ;13(11):12301-12321.
pmc_ranked_result_index: '16222'
pathway_score: 0.8929076
filename: nihms-1608678-f0005.jpg
figtitle: Illustration of aptamer involvement in cancer immunotherapy
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7382785__nihms-1608678-f0005.html
  '@type': Dataset
  description: Illustration of aptamer involvement in cancer immunotherapy. (A) Two
    most crucial (most known) immune checkpoints. (B) Antagonistic aptamers, selected
    against either receptor or ligand, inhibit their interaction. Therefore, the downstream
    pathway is not triggered. Agonistic aptamers dimerize receptor dimers that result
    in switching on respective signaling. (C) Selected immune system receptors that
    have already been targeted by aptamers. (D) Whereas standard approaches use aptamers
    as targeting agents to deliver therapeutic cargo to cells, aptamer-engineered
    NK cells are directed by cell-membrane-embedded aptamers to lymphoma cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - APC
  - CD274
  - CD86
  - CD80
  - TRA
  - TRB
  - TRD
  - TRG
  - CTLA4
  - CD28
  - HAVCR2
  - TNFRSF13C
  - TNFRSF9
  - CD40
  - TNFRSF4
  - TCR
  - cancer
  - APC
  - tumor
  - Lymphoma  Lymphoma
genes:
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: APC
  symbol: APC
  source: hgnc_symbol
  hgnc_symbol: APC
  entrez: '324'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: CD80/86
  symbol: CD86
  source: hgnc_symbol
  hgnc_symbol: CD86
  entrez: '942'
- word: CD80/86
  symbol: CD80
  source: hgnc_symbol
  hgnc_symbol: CD80
  entrez: '941'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: CD80/86
  symbol: CD86
  source: hgnc_symbol
  hgnc_symbol: CD86
  entrez: '942'
- word: CD80/86
  symbol: CD80
  source: hgnc_symbol
  hgnc_symbol: CD80
  entrez: '941'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: CTLA-4
  symbol: CTLA4
  source: hgnc_symbol
  hgnc_symbol: CTLA4
  entrez: '1493'
- word: CTLA-4
  symbol: CTLA4
  source: hgnc_symbol
  hgnc_symbol: CTLA4
  entrez: '1493'
- word: CTLA-4
  symbol: CTLA4
  source: hgnc_symbol
  hgnc_symbol: CTLA4
  entrez: '1493'
- word: CD28
  symbol: CD28
  source: hgnc_symbol
  hgnc_symbol: CD28
  entrez: '940'
- word: TIM-3
  symbol: TIM3
  source: hgnc_alias_symbol
  hgnc_symbol: HAVCR2
  entrez: '84868'
- word: BAFF-R
  symbol: BAFFR
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF13C
  entrez: '115650'
- word: 4-1BB
  symbol: 4-1BB
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF9
  entrez: '3604'
- word: CD40
  symbol: CD40
  source: hgnc_symbol
  hgnc_symbol: CD40
  entrez: '958'
- word: ОХ-40
  symbol: OX40
  source: hgnc_alias_symbol
  hgnc_symbol: TNFRSF4
  entrez: '7293'
chemicals:
- word: TCR
  source: MESH
  identifier: D017260
diseases:
- word: cancer
  source: MESH
  identifier: D009369
- word: APC
  source: MESH
  identifier: D011125
- word: tumor
  source: MESH
  identifier: D009369
- word: Lymphoma  Lymphoma
  source: MESH
  identifier: D008223
figid_alias: PMC7382785__F4
redirect_from: /figures/PMC7382785__F4
figtype: Figure
---
